pharmaceuticals
UnitedHealth Surpasses Quarterly Expectations and Raises Profit Outlook Amid Rising Medical Costs
UnitedHealth Group recently announced impressive first-quarter earnings, surpassing expectations and raising its profit outlook for 2026. The company, which is ... Read more
How Eli Lilly’s $3.25 Billion Acquisition of Kelonia Therapeutics Marks a Turning Point in the Startup’s Challenging Journey
Eli Lilly has announced a significant move: they are acquiring Kelonia Therapeutics for $3.25 billion. This small biotech firm specializes ... Read more
Congress Confronts a Full Plate: What’s on the Agenda for Health Care Reform?
Trump removed an AI-generated image of himself resembling Jesus after conservative Christians expressed their outrage. He explained to reporters that ... Read more
Eli Lilly’s Breakthrough Obesity Drug Retatrutide Triumphs in First Late-Stage Diabetes Trial: What It Means for You
Eli Lilly is making waves with its new obesity drug, retatrutide. Recently, it passed a critical late-stage trial focusing on ... Read more
FDA’s New Move Against UniQure Sparks Controversy: What You Need to Know
During a recent media call organized by the FDA, a senior official spoke about UniQure and its experimental Huntington’s disease ... Read more
Trump’s Controversial Glyphosate Order Sparks MAHA Outrage—How This Could Empower Democrats
In recent news, the Make America Healthy Again (MAHA) movement faces unexpected challenges from the Trump administration. President Trump signed ... Read more
Inside Hims’ Earnings Call: CEO Tackles GLP-1 Compounding Concerns Head-On
In recent times, telehealth company Hims & Hers has sparked discussions about compounded GLP-1 weight loss medications. During a recent ... Read more
Novo Nordisk Shares Drop 15% as Weight Loss Drug Fails to Compete with Eli Lilly’s Breakthrough in Latest Trial
Novo Nordisk’s stock dropped by 15% on Monday after news that its weight-loss drug, CagriSema, did not meet its main ... Read more
New FDA Guidelines on Antibiotic Use in Farm Animals: A Double-Edged Sword in the Fight Against Antibiotic Resistance
In an effort to combat antibiotic resistance, the U.S. Food and Drug Administration (FDA) has released new guidelines for drug ... Read more
FDA Changes Its Stance: A New Review of Moderna’s Flu Vaccine is on the Horizon!
The FDA recently announced it will review Moderna’s application for a new flu vaccine, specifically for adults aged 50 and ... Read more
